Evidence map›Paper›PMID 34068744›Full record

ArticleMicroorganisms2021

Genomic and Phenotypic Analysis of Linezolid-Resistant

Silke Huber, Miriam A Knoll, Michael Berktold, Reinhard Würzner, Anita Brindlmayer, Viktoria Weber, Andreas E Posch, Katharina Mrazek, Sarah Lepuschitz, Michael Ante and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Investigation of a linezolid-resistantFrontiers in microbiology · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Look Who's Talking: Host and Pathogen Drivers ofInternational journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Silke HuberInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0002-7021-1845
Miriam A KnollInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Michael BerktoldInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Reinhard WürznerInstitute of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-6804-442X
Anita BrindlmayerCenter for Biomedical Technology, Department for Biomedical Research, Danube University Krems, 3500 Krems, Austria.
Viktoria WeberCenter for Biomedical Technology, Department for Biomedical Research, Danube University Krems, 3500 Krems, Austria.ORCID 0000-0002-3963-9077
Andreas E PoschAres Genetics GmbH, 1030 Vienna, Austria.
Katharina MrazekAres Genetics GmbH, 1030 Vienna, Austria.
Sarah LepuschitzAres Genetics GmbH, 1030 Vienna, Austria.
Michael AnteAres Genetics GmbH, 1030 Vienna, Austria.ORCID 0000-0001-5803-2409
Stephan BeiskenAres Genetics GmbH, 1030 Vienna, Austria.
Dorothea Orth-HöllerMB-LAB-Clinical Microbiology Laboratory, 6020 Innsbruck, Austria.
Johannes WeinbergerAres Genetics GmbH, 1030 Vienna, Austria.ORCID 0000-0002-4671-7846
Innsbruck Medical University · ATUniversität für Weiterbildung Krems · AT

Funding

Austrian Science Fund FWF W 1253Österreichische Forschungsförderungsgesellschaft 871243
6 · The paper itself

Abstract

Whole genome sequencing is a useful tool to monitor the spread of resistance mechanisms in bacteria. In this retrospective study, we investigated genetic resistance mechanisms, sequence types (ST) and respective phenotypes of linezolid-resistant

Indexed as

antimicrobial resistancelinezolidStaphylococcus epidermidissurveillancewhole genome sequencing

Identifiers

PMID34068744
PMCPMC8150687
OpenAlexW3162924746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.